Jump Financial’s Precision BioSciences DTIL Stock Holding History

Jump Financial’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$525K	Buy	66,800 +15,527	+30%	+$109K	﹤0.01%	1436
2026 Q1	$282K	Buy	51,273 +15,483	+43%	+$71.4K	﹤0.01%	1512
2025 Q4	$149K	Buy	+35,790	New	+$203K	﹤0.01%	1791
2022 Q3	–	Sell	-337	Closed	-$16K	–	1666
2022 Q2	$16K	Buy	+337	New	+$19.8K	﹤0.01%	1545
2021 Q3	–	Sell	-2,647	Closed	-$994K	–	1192
2021 Q2	$994K	Buy	2,647 +2,009	+315%	+$603K	0.1%	278
2021 Q1	$198K	Buy	+638	New	+$223K	0.02%	764

Other funds holding DTIL

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Jump Financial's DTIL Position: Q2 2026 in Review

Jump Financial increased its Precision BioSciences (DTIL) stake by 30% in Q2 2026, buying an estimated $109K and bringing the position to 66,800 shares worth $525K. The position accounts for ﹤0.01% of the portfolio, ranked #1436.

Jump Financial first reported a position in DTIL in Q1 2021 and has held it in 6 quarters since. The position peaked at $994K in Q2 2021. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

Jump Financial held 66,800 shares of Precision BioSciences worth $525K as of Q2 2026.
Jump Financial bought 15,527 Precision BioSciences shares in Q2 2026, an estimated $109K.
Precision BioSciences made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1436 holding.
Jump Financial first reported a position in Precision BioSciences in Q1 2021 and has held it in 6 quarters since.
Jump Financial's Precision BioSciences position peaked at $994K in Q2 2021.
95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.